Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly and Co

Recent news which mentions Eli Lilly and Co

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
'Don't quit the market' when it's frothy, says Jim Cramer. Here's why
Tags Mad Money U/S/ Markets Stock markets
From CNBC.com News
Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs
Tags Biotech and Pharmaceuticals Biotechnology Business
From CNBC.com News
Cramer's Lightning Round: Affirm is a buy
Tags ServiceNow Inc Business Market Outlook
From CNBC.com News
5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista
Tags Economy 5 Things to Know Eli Lilly and Co
From CNBC.com News
Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar
Tags Breaking News: Earnings Pharmaceuticals US: News
From CNBC.com News
Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval
Tags Health care industry Companies Health & Science
From CNBC.com News
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
Tags Pfizer Inc Novo Nordisk A/S AstraZeneca PLC
From CNBC.com News
5 things to know before the Monday open: Berkshire's tariff fears | Ethereum turns 10 | Restaurants embrace spicy
Tags Yum! Brands Inc CAVA Group Inc Business
From CNBC.com News
Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's
Tags Wendys Co Eli Lilly and Co Investing
From CNBC.com News
Trump's drug price ultimatum sets pharma firms scrambling
Tags Amgen Inc Trade Eli Lilly and Co
From CNBC.com News
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Tags Health care industry Companies Health & Science
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags Novartis AG Roche Holding AG Business News
From CNBC.com News
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
Tags Pharmaceuticals US: News Eli Lilly and Co
From CNBC.com News
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
Tags Novo Nordisk A/S Regeneron Pharmaceuticals Inc Health care industry
From CNBC.com News
Cramer's Lightning Round: Rocket Lab is a buy
Tags Markets Eli Lilly and Co stocks
From CNBC.com News
Trump's 200% tariff threat leaves pharma firms scrambling with scenario planning
Tags Trade Eli Lilly and Co Europe News
From CNBC.com News
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Tags Hims & Hers Health Inc Health care industry Companies
From CNBC.com News
Trump threatens to put up to 200% tariff on pharmaceuticals 'very soon'
Tags Business News Breaking News: Business Biotechnology
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Halliburton Co DaVita Inc Chipotle Mexican Grill Inc
From CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
Tags U/S/ Economy Labor issues Labor unions
From CNBC.com News
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
Tags Transportation Strikes Walmart Inc
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
Tags Biotech and Pharmaceuticals Social issues Business News
From CNBC.com News
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
Tags Health care industry Health & Science Companies
From CNBC.com News
Tuesday's big stock stories: What's likely to move the market in the next trading session
Tags United States Steel Corp Williams Companies Inc Investing
From CNBC.com News
FTC sues drug middlemen for allegedly inflating insulin prices
Tags UnitedHealth Group Inc Companies Breaking News: Politics
From CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
Tags Biotechnology Novo Nordisk A/S Health & Science
From CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Tags Roche Holding AG Biotech and Pharmaceuticals Social issues
From CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
Tags AstraZeneca PLC Bristol/Myers Squibb Co Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
Tags Biotech and Pharmaceuticals Business Biotechnology
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
Tags Novo Nordisk A/S Health & Science Health care industry
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS